Tailor-made Antibodies
and Tools for Life Science
Home|||||Technical Support

Collagen type IV antibody - 462 017

Collagen type IV is a basement membrane protein
Rat monoclonal purified IgG
Cat. No.: 462 017
Amount: 100 µg
Price: $415.00
Cat. No. 462 017 100 µg purified IgG, lyophilized. Albumin and azide were added for stabilization. For reconstitution add 100 µl H2O to get a 1mg/ml solution in PBS. Then aliquot and store at -20°C to -80°C until use.
Antibodies should be stored at +4°C when still lyophilized. Do not freeze!
Applications
 
ICC: not tested yet
IHC: 1 : 500 up to 1 : 1000 (see remarks) gallery  
IHC-P: 1 : 500 up to 1 : 1000 (see remarks) gallery  
IHC-Fr: 1 : 500 up to 1 : 1000 (see remarks) gallery  
Clone SY-245D2
Subtype IgG2a (κ light chain)
Immunogen Human heterotrimeric Collagen type IV containing two α 1-like (UniProt Id: P02462) and one α 2-like (UniProt Id: P08572) chains.
Reactivity Reacts with: mouse (P02463), mouse (P08122), human (P02462), human (P08572).
No signal: rat (F1MA59), rat (F1M6Q3).
Other species not tested yet.
Remarks

IHC: Antigen retrieval (10mM citrate, pH 6.0, overnight at 60°C or 0.2 mg/ml pepsin in 0.2 M HCl for 20 min at 37 °C) are recommended
IHC-P: Antigen retrieval with Tris-EDTA buffer pH 9.0 in a food steamer followed by pepsin treatment or a Citrate buffer pH 6.0 antigen retrieval followed by pepsin treatment are recommended.
IHC-Fr: 4% FA, Methanol, Acetone and Methanol-acetone mix 1:1 fixation is possible

Data sheet 462_017.pdf
Cat. No.: 462 017
Amount: 100 µg
Price: $415.00
Background

Type IV collagen is a unique member of the large collagen superfamily which in vertebrates comprises 28 different types. Unlike most collagens, type IV collagen occurs only in the basement membranes (BMs) and comprises up to six genetically distinct α-chains designated α1(IV) to α6(IV). Out of many potential combinations, the chains interact and assemble with a remarkable specificity to form only three distinct heterotrimers of α1α1α2, α3α4α5, and α5α5α6 (1). It has been shown that ablation of COL4 α 1/2 results in abnormal BM structure and embryonic lethality at E10.5–E11.5, although BM formation during early development is unaffected (2).